Document is current
Any future updates will be listed below
-
Authors
Mebrahtu, Aman
Laurén, Ida https://orcid.org/0000-0003-0041-6084
Veerman, Rosanne
Akpinar, Gözde Güclüler
Lord, Martin https://orcid.org/0000-0002-3238-3187
Kostakis, Alexandros https://orcid.org/0009-0006-2252-2645
Astorga-Wells, Juan https://orcid.org/0000-0003-1017-8841
Dahllund, Leif
Olsson, Anders
Andersson, Oscar
Persson, Jonathan
Persson, Helena
Dönnes, Pierre https://orcid.org/0000-0002-4613-2952
Rockberg, Johan
Mangsbo, Sara https://orcid.org/0000-0002-1355-2678
-
Funding
Funding for this research was provided by:
Cancerfonden (22 2219 Pj)
Knut och Alice Wallenbergs Stiftelse (2020.0182)
- License Information
-
More Information
Article History
Received: 4 July 2023
Accepted: 23 October 2024
First Online: 5 November 2024
Competing interests
: The authors declare the following competing interests: The presented study has been partly funded by Strike Pharma AB, whose long-term value can be influenced by the publication of the paper. S.M., J.R., A.M., I.L., M.L., and P.D. hold private stakes in Strike Pharma AB, whose long-term value can be influenced by the publication of the paper. R.V. is a current employee, and G.G.A. was an employee at Strike Pharma AB when the presented work was carried out. The rest of the authors declare no competing interest.
